Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Pharma Industry News FDA puts clinical hold on Selecta Biosciences SEL-302 phase 1/2 trial Selecta Biosciences said that the US Food and Drug Administration (FDA) has imposed a clinical hold on its… bySrinathNovember 27, 2021
